ESCAPE Bio is a preclinical stage biopharmaceutical company focused on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. We are passionate about making a meaningful clinical impact for patients suffering from CNS diseases and believe in a genetically defined approach to achieving this goal.
| Website | http://www.escapebio.com/ |
| Employees | 9 (5 on RocketReach) |
| Founded | 2015 |
| Address | 4000 Shoreline Court Suite 400, South San Francisco, California 94080, US |
| Phone | +1 415-294-8748 |
| Industry | Biotechnology, Drug Discovery, Science and Engineering, Pharmaceuticals, Health Care, Medical |
| Keywords | Neurodegenerative Diseases, Biopharmaceutical, Genetic Diseases, Biotechnology, Gene Therapy, Preclinical Development, Drug Discovery, Therapeutics, Neurology, Precision Medicine, Pharmaceutical Research, Drug Development, Degenerative Diseases, Rare Diseases, Molecular Biology, Clinical Trials, Alzheimers, Parkinsons, Clinical Research |
| Competitors | Roche, Novartis, AbbVie, Sanofi, AstraZeneca, Amgen, Regeneron, Vertex Pharmaceuticals, Biogen, Lilly India +39 more (view full list) |
Looking for a particular ESCAPE Bio employee's phone or email?
Teresa McWhirt is the Senior Vice President and Head of Human Resources of ESCAPE Bio.
5 people are employed at ESCAPE Bio.
ESCAPE Bio is based in South San Francisco, California.